La Jolla Pharmaceutical Company
(NASDAQ CM: LJPC)
Rigrodsky Law, P.A. is investigating La Jolla Pharmaceutical Company (“La Jolla”) regarding possible breaches of fiduciary duties and other violations of law related to La Jolla’s agreement to be acquired by Innoviva Inc. Under the terms of the agreement, La Jolla’s shareholders will receive $6.23 in cash for each share of La Jolla common stock they own.